PHG - Philips Achieves Strong Q3 Sales Growth Despite Lower Order Intake Boosts FY23 Outlook | Benzinga
Koninklijke Philips NV (NYSE: PHG) reported a Q3 FY23 comparable sales growth of 11% Y/Y to €4.5 billion ($4.87 billion), driven by growth across all segments and geographies.
Comparable sales for Diagnosis & Treatment businesses grew by 14%, with double-digit growth in Latin America, China, the Middle East & Turkey, and mature geographies.
The comparable sales in the Connected Care businesses increased by 10% Y/Y, led by double-digit growth in Monitoring and mid-single-digit growth in Enterprise Informatics.
The Personal Health businesses recorded a comparable sales growth of 7% Y/Y, led by high-single-digit growth in Personal Care and Oral Healthcare.
Comparable order ...